TrialDigestive diseases and sciences2022
Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Bruno Bockorny et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it